Rhythm Pharmaceuticals ($RYTM) Insider Trading & Smart Money Activity
Rhythm Pharmaceuticals, Inc. ($RYTM) has 17 insider trades, 2 13F position changes and 3 analyst ratings on file. Insiders filed 17 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 3
RYTM insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 1 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 1 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All RYTM insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | Aspiriant | Reduced | -20.07K sh | $751.06K | — | ||||||
| Insider | Lynn Tetrault | Buy (Grant or award) | 3.69K sh | +2.7% | -5.1% | — | |||||
| Insider | David Mcgirr | Buy (Grant or award) | 3.69K sh | +2.7% | -5.1% | — | |||||
| Insider | Christophe Jean | Buy (Grant or award) | 3.69K sh | +2.7% | -5.1% | — | |||||
| Insider | Jennifer Good | Buy (Grant or award) | 2.32K sh | +2.7% | -5.1% | — | |||||
| Insider | Stuart Arbuckle | Buy (Grant or award) | 3.69K sh | +2.7% | -5.1% | — | |||||
| Insider | Lynn Tetrault | Sell (Option exercise) | 4.71K sh | +4.6% | -3.3% | — | |||||
| Insider | Lynn Tetrault | Buy (Option exercise) | 4.71K sh | +4.6% | -3.3% | — | |||||
| Insider | David Mcgirr | Sell (Option exercise) | 4.71K sh | +4.6% | -3.3% | Read | |||||
| Insider | David Mcgirr | Buy (Option exercise) | 4.71K sh | +4.6% | -3.3% | Read | |||||
| Insider | Christophe Jean | Sell (Option exercise) | 4.71K sh | +4.6% | -3.3% | Read | |||||
| Insider | Christophe Jean | Buy (Option exercise) | 4.71K sh | +4.6% | -3.3% | — | |||||
| Insider | Jennifer Good | Sell (Option exercise) | 4.71K sh | +4.6% | -3.3% | Read | |||||
| Insider | Jennifer Good | Buy (Option exercise) | 4.71K sh | +4.6% | -3.3% | — | |||||
| Insider | Stuart Arbuckle | Sell (Option exercise) | 4.71K sh | +4.6% | -3.3% | — | |||||
| Insider | Stuart Arbuckle | Buy (Option exercise) | 4.71K sh | +4.6% | -3.3% | — | |||||
| Insider | Lynn Tetrault | Sell (Option exercise) | 37K sh | +8.5% | +2.5% | — | |||||
| Insider | Lynn Tetrault | Buy (Option exercise) | 37K sh | $1.05M | +8.5% | +2.5% | Read | ||||
| Analyst | Canaccord Genuity | Reiterates to buy | PT $151 | +18.4% | +18.2% | Read | |||||
| Analyst | Wells Fargo | Reiterates to buy | PT $155 | +13.0% | +22.3% | Read | |||||
| Analyst | Wells Fargo | Reiterates to buy | PT $155 | +13.0% | +22.3% | Read | |||||
| 13F | Primecap Management | Reduced | -61.16K sh | $379.45M | -0.6% | -1.9% | Read |
1W / 1M / 6M = how RYTM moved from the trade or filing date.
Insider trading in RYTM: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Lynn Tetrault | 5 | — | Jun 24, 2026 | ||
| David Mcgirr | 3 | — | Jun 24, 2026 | ||
| Christophe Jean | 3 | — | Jun 24, 2026 | ||
| Jennifer Good | 3 | — | Jun 24, 2026 | ||
| Stuart Arbuckle | 3 | — | Jun 24, 2026 |
Institutions moving RYTM (13F)
Analyst ratings on RYTM
Frequently asked questions
What is the latest insider trade in RYTM?
Lynn Tetrault filed a buy (grant or award) of 3.69K sh on Jun 24, 2026.
Which institutions changed their RYTM positions?
Recent 13F filers moving the stock include Aspiriant and Primecap Management.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.